DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Halobetasol Propionate is a drug marketed by Cosette, Fougera Pharms, Padagis Israel, Taro, Quagen, and Teligent. and is included in twelve NDAs.
The generic ingredient in HALOBETASOL PROPIONATE is halobetasol propionate. There are nine drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the halobetasol propionate profile page.
A generic version of HALOBETASOL PROPIONATE was approved as halobetasol propionate by FOUGERA PHARMS on December 16th, 2004.
Summary for HALOBETASOL PROPIONATE
|Finished Product Suppliers / Packagers:||10|
|Raw Ingredient (Bulk) Api Vendors:||41|
|Drug Prices:||Drug price information for HALOBETASOL PROPIONATE|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for HALOBETASOL PROPIONATE|
|What excipients (inactive ingredients) are in HALOBETASOL PROPIONATE?||HALOBETASOL PROPIONATE excipients list|
|DailyMed Link:||HALOBETASOL PROPIONATE at DailyMed|
Recent Clinical Trials for HALOBETASOL PROPIONATE
Identify potential brand extensions & 505(b)(2) entrants
|Skin Sciences, PLLC||Phase 4|
|Bausch Health Americas, Inc.||Phase 4|
|Mayne Pharma International Pty Ltd||Phase 4|